Introduction and application of CAS No.162401-32-3 | Roflumilast
Roflumilast is a selective phosphodiesterase-4 inhibitor that is used for the treatment of exacerbations in patients with chronic obstructive pulmonary disease (COPD). It is also used to treat plaque psoriasis. This drug has anti-inflammatory and immunomodulatory effects as it aids in increasing levels of cAMP.
Synonyms:
3-(Cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide;
Specification of CAS No.162401-32-3 | Roflumilast
|
ITEMS |
SPECIFICATION |
|
CAS |
162401-32-3 |
|
MF |
C17H14Cl2F2N2O3 |
|
MW |
403.21 |
|
Melting point |
158°C |
|
Boiling point |
430.6±45.0 °C(Predicted) |
|
Density |
1.471±0.06 g/cm3(Predicted) |
|
acidity coefficient(pKa) |
9.89±0.70(Predicted) |
Package and transportation of Introduction and application of CAS No.162401-32-3 | Roflumilast
Package:0.1g,1g,5g,25g,100g,500g,1kg
Transportation: by courier/ by air/ by sea
Related Articles of CAS No.162401-32-3 | Roflumilast
Roflumilast: a review of its use in the treatment of COPD
JA Wedzicha, PM Calverley… - International journal of …, 2016 - Taylor & Francis
… Roflumilast is a potent and selective inhibitor of the enzyme … Several clinical trials evaluating
roflumilast in the treatment of … Data suggest that roflumilast reduces moderate to severe …
Hot Tags: cas no.162401-32-3 | roflumilast, China cas no.162401-32-3 | roflumilast manufacturers, factory, Pharmaceutical Intermediates, 2-Bromo-m-xylene, Cordycepin, 4 Amino 4H 1 2 4 triazole, 3 deoxy adenosin, Cellulose Acetate Butyrate
